AbbVie’s $63 Billion Acquisition of Allergan Wins FTC Nod with Divestitures
- May 08, 2020
The Federal Trade Commission (FTC) cleared May 5 drug maker AbbVie Inc.’s acquisition of rival Allergan plc after the companies agreed to divest three drug products.
ARTICLE TAGS
You must be logged in to access this content.